Back to Chevy Chase Trust Holdings, LLC Chevy Chase Trust Holdings, LLC

NTLA

26 quarters

Position history for Chevy Chase Trust Holdings, LLCChevy Chase Trust Holdings, LLC's holdings in Intellia Therapeutics, Inc.

No. Chevy Chase Trust Holdings exited its NTLA (Intellia Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 288,321 shares worth $3.4M. Chevy Chase Trust Holdings already held NTLA in its Q4 2018 13F, the earliest on record, and held it in 25 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$9.5M

Total Shares Change

-695,336

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$7.11
0
2024-Q4
Decreased
288,321
-64.5%
$3.4M0.0%$11.66
0
2024-Q3
Decreased
811,033
-22.2%
$16.7M0.1%$20.55
0
2024-Q2
Decreased
1M
-3.0%
$23.3M0.1%$22.38
0
2024-Q1
Increased
1.1M
+8.4%
$29.6M0.1%$27.51
31
2023-Q4
Decreased
991,175
-1.2%
$30.2M0.1%$30.49
0
2023-Q3
Increased
1M
+3.0%
$31.7M0.1%$31.62
36
2023-Q2
Increased
973,543
+3.9%
$39.7M0.1%$40.78
36
2023-Q1
Decreased
937,066
-3.6%
$34.9M0.1%$37.27
0
2022-Q4
Decreased
972,076
-14.5%
$33.9M0.1%$34.89
0
2022-Q3
Increased
1.1M
+9.8%
$63.7M0.3%$55.96
39
2022-Q2
Decreased
1M
-1.9%
$53.6M0.2%$51.76
0
2022-Q1
Decreased
1.1M
-7.2%
$76.8M0.3%$72.67
0
2021-Q4
Decreased
1.1M
-1.8%
$134.6M0.4%$118.24
0
2021-Q3
Decreased
1.2M
-7.0%
$155.4M0.5%$134.15
0
2021-Q2
Decreased
1.2M
-5.9%
$201.8M0.7%$161.91
0
2021-Q1
Decreased
1.3M
-19.0%
$106.3M0.4%$80.26
0
2020-Q4
Decreased
1.6M
-9.3%
$89M0.3%$54.40
0
2020-Q3
Increased
1.8M
+15.8%
$35.9M0.1%$19.88
40
2020-Q2
Increased
1.6M
+12.5%
$32.8M0.1%$21.02
39
2020-Q1
Increased
1.4M
+3.9%
$16.9M0.1%$12.23
29
2019-Q4
Increased
1.3M
+6.2%
$19.6M0.1%$14.67
30
2019-Q3
Increased
1.3M
+14.1%
$16.8M0.1%$13.35
32
2019-Q2
Increased
1.1M
+15.0%
$18M0.1%$16.37
32
2019-Q1
Increased
956,511
+37.6%
$14.7M0.1%$17.08
37
2018-Q4
First report
695,336
-
$9.5M0.0%$13.65
0

Other major holders of NTLA: ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used